BackEastwood Bio-Medical Canada Overview

Eastwood Bio-Medical Canada Profit Margin

Latest profit margin for Eastwood Bio-Medical Canada: -74.09% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

-61.39%
↑ 2.12% YoY

As of Jul 2024

Annual Profit Margin (TTM)

-74.09%
↓ 105.01% YoY

Trailing 12 months ending Jul 2024

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Eastwood Bio-Medical Canada (EBM.V) FAQ

As of the most recent data (July 2024), EBM.V shows a profit margin of -74.09%. That compares with -36.14% in the prior-year period — down 105.0% year over year. That is below the sector sector average of 13.4%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EBM.V's profit margin is now -74.09% (was -36.14%) — a 105.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Eastwood Bio-Medical Canada is outperforming or lagging.

The its sector sector average profit margin is about 13.4%. Eastwood Bio-Medical Canada is at -74.09%, which is lower that average. That is roughly 652.7% below the sector mean. Use the comparison chart on this page to see how EBM.V stacks up against individual peers as well.

That compares with -36.14% in the prior-year period — down 105.0% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Eastwood Bio-Medical Canada with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Eastwood Bio-Medical Canada's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -74.09%) with ownership activity and broader fundamentals.